Boceprevir, calpain inhibitors II and XII, and GC-376 have broad-spectrum antiviral activity against coronaviruses in cell culture is a research paper published in bioRxiv (Cold Spring Harbor Laboratory) (2020). On theSindex it has a DataRank of 0. It has been cited 15 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Institutes of Health
Grant: 1R21AI119187-01
Drug Discovery Targeting the Influenza A Virus M2-S31N Proton Channel
National Institutes of Health
Grant: 7R01AI147325-04
High Throughput Screening of Inhibitors Targeting the Enterovirus A71 and D68 2A proteases
National Institutes of Health
Grant: 1R21AI144887-01
Discovery of broad-spectrum influenza antivirals with a high genetic barrier to drug resistance by targeting the viral polymerase
National Institutes of Health
Grant: 7R01AI157046-03
Drug target validation of the enterovirus D68 2A protease
NIAID NIH HHS
Grant: R33 AI119187
NIAID NIH HHS
Grant: R21 AI119187
NIAID NIH HHS
Grant: R01 AI157046
NIAID NIH HHS
Grant: R01 AI147325
NIAID NIH HHS
Grant: R21 AI144887
Fields of Study
Keywords
Sustainable Development Goals